Customer Communications include the latest customer letters and updates regarding ICU Medical products. These documents are organized in date descending order. Specific Clinical Bulletins can be accessed separately. For additional information, please refer to specific contact information in the individual letter or, for general inquiries, contact ICU Medical.
Documents are offered in PDF format for your convenience. PDF documents require Adobe Acrobat Reader to view and print. If you do not have Adobe Acrobat Reader, you can download the free software here.
|Release Date||Product||Title||ICU Medical Reference|
|10/30/19||Lactated Ringer's Injection, USP||Hospira Intravenous (IV) Solutions Urgent Drug Recall||Customer Letter|
|10/30/19||0.9% Sodium Chloride Injection, USP||Hospira Intravenous (IV) Solutions Urgent Drug Recall||Customer Letter|
|10/12/18||Hospira Intravenous (IV) solutions||Hospira Intravenous (IV) Solutions Expanded Recall||Customer Letter|
|6/6/18||Hospira intravenous (IV) solutions||Hospira Intravenous (IV) Solutions Voluntary Recall||Customer Letter|
|10/28/16||Pfizer Injectables||Pfizer Injectables National Drug Code Labeling Updates||Customer Letter|
|10/06/16||Technical Service Bulletin||Observing Excessive Moisture||P19-4453|
An unknown error occurred.
Your submission has been received!